Sort
48,018 grants matching “immunotherapy”
Fluorescence tomography plugin unit for spatial monitoring of T cell migration
$704,391Alexander D. Klose · In Vivo Analytics, Inc. · R44 · FY2020 · CA
Mechanisms of cancer immunotherapy-associated thrombosis
$704,368Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL
Synthetic toolkit for precision gene expression control and signal processing in mammalian cells
$704,349Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2020 · EB
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$704,036Lorna Rodriguez-Rodriguez · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$703,942Harvinder Singh Gill · Texas Tech University · R01 · FY2020 · AI
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
$703,914Manish Sagar · Boston Medical Center · R01 · FY2024 · AI
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
$703,914Manish Sagar · Boston Medical Center · R01 · FY2023 · AI
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$703,909Kwok Kin Wong · New York University School Of Medicine · U01 · FY2017 · CA
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$703,880Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2022 · AI
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$703,710Vaccine Research Institute Of San Diego · R01 · FY2005 · AI
Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices
$703,540Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2025 · CA
Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
$703,510Derin B Keskin · Dana-Farber Cancer Inst · R01 · FY2025 · CA
A prospective study of circulating autoantibodies and breast cancer risk in the NYU Womenâs Health Study
$703,423Yu Chen · New York University School Of Medicine · U01 · FY2025 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$703,320Benjamin G. Neel · New York University School Of Medicine · R01 · FY2025 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$703,320Benjamin G. Neel · New York University School Of Medicine · R01 · FY2021 · CA
The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care
$703,293Nancy L Keating · Harvard Medical School · R01 · FY2025 · CA
IN VITRO APPROACH TO PROBLEMS OF CLINICAL ALLERGY
$703,279Johns Hopkins University · R01 · FY2000 · AI
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
$703,258James E Crowe · Vanderbilt University Medical Center · R01 · FY2023 · AI
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
$703,258Isaac P Thomsen · Vanderbilt University Medical Center · R01 · FY2022 · AI
Beta-Amyloid Immunization in a Canine Model of Aging
$703,198Elizabeth Head · University Of Kentucky · R01 · FY2010 · AG
Signal and Transcription Factor Network interactions in Head and Neck Cancer
$703,181Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$703,176Benjamin G. Neel · New York University School Of Medicine · R01 · FY2021 · CA
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$703,154Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2025 · CA
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
$703,149Lorenzo Galluzzi · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$703,025Mark Yarchoan · Johns Hopkins University · R01 · FY2023 · CA